Literature DB >> 2472993

Association of a lipoprotein-like particle with bovine fetuin.

L Kumbla1, A J Cayatte, M T Subbiah.   

Abstract

Fetuin is a major protein of fetal bovine serum that exhibits heterogeneity and has been found to be associated with some biological active growth factors. Preliminary studies indicated that commercial fetuin preparations contain lipids. We investigated in detail the nature of lipids associated with fetuin by using ultracentrifugation and agarose gel chromatography followed by lipid analysis. Fetuin was associated with a variety of lipids, predominantly cholesterol, cholesteryl ester with smaller amounts of phospholipids, triglycerides, and free fatty acids. Adjustment of fetuin preparation for various densities followed by ultracentrifugation resulted in a fraction with a density 1.063-1.21 g/ml (1-2% of total protein) that contained the bulk of the lipids. This fraction eluted as a single peak upon high pressure liquid chromatography and agarose gel chromatography. Delipidation of the lipoprotein-like particle followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis indicated a major band in the range of fetuin itself. These studies suggest that a fraction of fetuin (or isoform) binds lipids forming a particle with floating characteristics similar to high density lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472993     DOI: 10.1096/fasebj.3.9.2472993

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  3 in total

1.  Fetuin: an acute phase protein in cattle.

Authors:  K M Dziegielewska; W M Brown; C C Gould; N Matthews; J E Sedgwick; N R Saunders
Journal:  J Comp Physiol B       Date:  1992       Impact factor: 2.200

2.  Biochemical aspects and functional role of the copper-containing amine oxidases.

Authors:  F Buffoni; G Ignesti
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

3.  A novel function of N-linked glycoproteins, alpha-2-HS-glycoprotein and hemopexin: Implications for small molecule compound-mediated neuroprotection.

Authors:  Takuya Kanno; Kaori Yasutake; Kazunori Tanaka; Shinji Hadano; Joh-E Ikeda
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.